Possible Rationale for Procaine (Gerovital H3) Therapy in Geriatrics: Inhibition of Monoamine Oxidase
- 1 September 1973
- journal article
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 21 (9) , 414-418
- https://doi.org/10.1111/j.1532-5415.1973.tb01701.x
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- AGEING, MONOAMINES, AND MONOAMINE-OXIDASE LEVELSThe Lancet, 1972
- MULTIPLE FORMS OF MONOAMINE OXIDASE IN DEVELOPING BRAIN: TISSUE AND SUBSTRATE SPECIFICITIESJournal of Neurochemistry, 1971
- Relation of Sex and Aging to Monoamine Oxidase Activity of Human Brain, Plasma, and PlateletsArchives of General Psychiatry, 1971
- Multiple Forms of Rat Brain Monoamine OxidaseNature, 1969
- Relationship of Monoamine Metabolites in Human Cerebrospinal Fluid to AgeNature, 1968
- The Effects of a European Procaine Preparation in an Aged PopulationJournal of Gerontology, 1965
- The Effects of a European Procaine Preparation in an Aged PopulationJournal of Gerontology, 1965
- PHARMACOLOGIC STUDIES OF SOME NONHYDRAZINE MAO INHIBITORSAnnals of the New York Academy of Sciences, 1963
- TREATMENT OF HOSPITALIZED DEPRESSED AND SCHIZOPHRENIC PATIENTS WITH MONOAMINE OXIDASE INHIBITORS: INCLUDING REFLECTIONS ON PARGYLINE*Annals of the New York Academy of Sciences, 1963
- Effect of l-DOPA and N-Methyl-N-benzyl-2-propynylamine.HCl on DOPA, dopamine, norepinephrine, epinephrine and serotonin levels in mouse brainBiochemical Pharmacology, 1961